Another interesting fact:
EBITDA $217m from the investor presentation December 2105
EBITDA US$330 million from the AGM presentation May 2016.
Read between the lines on prospective recoveries....something/s have moved considerably in favour of the bottom line over the past few months and my guess is recoveries and the off-take agreement have combined to give us an excellent outcome.
- Forums
- ASX - By Stock
- AVB
- Ann: Results of Annual General Meeting-AVB.AX
Ann: Results of Annual General Meeting-AVB.AX, page-129
-
- There are more pages in this discussion • 189 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online